Jaguar Health Granted Nasdaq Extension, Plans 1-for-35 Reverse Stock Split on April 30
Jaguar Health received a Nasdaq panel extension until May 15, 2026 to demonstrate a $1.00 closing bid price for ten consecutive business days to maintain its Capital Market listing. The company will implement a 1-for-35 reverse stock split effective April 30, 2026, triggering split-adjusted trading and a new CUSIP.
1. Nasdaq Compliance Extension
On April 24, Jaguar Health received formal notice granting it until May 15, 2026 to comply with the $1.00 bid price rule, requiring a closing bid of at least $1.00 for ten consecutive business days. The Nasdaq panel may defer its determination up to 20 business days beyond this deadline.
2. Reverse Stock Split Execution
At its April special meeting, Jaguar approved a 1-for-35 reverse split effective April 30, 2026, after which its common stock will trade on a split-adjusted basis under CUSIP 47010C862. No fractional shares will be issued; holders of fractional entitlements will receive cash in lieu.
3. Next Steps and Fractional Shares
Equiniti Trust Company is acting as exchange agent to process share certificates for record holders, while brokerage account holders need take no action. The company must monitor its post-split share price to achieve the $1.00 threshold and maintain its Nasdaq Capital Market listing.